NASDAQ:VRTX | EBITDA | VERTEX PHARMACEUTICALS INC / MA

Complete source-backed ebitda history.

Available history
2008-12-31 to 2026-06-30
Data captured

Historical EBITDA

DateEBITDA
2026-06-30$1.3B
2026-03-31$1.19B
2025-12-31$1.26B
2025-09-30$1.24B
2025-06-30$1.2B
2025-03-31$678.5M
2024-12-31$1.07B
2024-09-30$1.17B
2024-06-30-$3.46B
2024-03-31$1.19B
2023-12-31$1.05B
2023-03-31$817.8M
2022-12-31$1.07B
2022-03-31$1.08B
2021-12-31$911.5M
2021-03-31$916.6M
2020-12-31$775.14M
2020-03-31$747.05M
2019-12-31$577.61M
2019-03-31$303.95M
2018-12-31$146.55M
2018-03-31$145.24M
2017-12-31$142.17M
2017-03-31$285.69M
2016-12-31$55.09M
2016-03-31$2.09M
2015-12-31-$37.96M
2015-03-31-$155.62M
2014-12-31-$137.29M
2014-03-31-$200.25M
2013-12-31$7.35M
2013-03-31-$427.6M
2012-12-31-$20.71M
2012-03-31$100.21M
2011-12-31$233.63M
2011-03-31-$151.04M
2010-12-31-$158.43M
2010-03-31-$152.7M
2009-12-31-$138.34M
2009-03-31-$154.73M

Annual EBITDA

DateEBITDA
2025-12-31$4.38B
2024-12-31-$25.7M
2023-12-31$4.01B
2022-12-31$4.46B
2021-12-31$2.91B
2020-12-31$2.97B
2019-12-31$1.3B
2018-12-31$707.57M
2017-12-31$184.64M
2016-12-31$71.33M
2015-12-31-$404.54M
2014-12-31-$629.16M
2013-12-31-$561.64M
2012-12-31$84.92M
2011-12-31$148.86M
2010-12-31-$665.62M
2009-12-31-$583.91M
2008-12-31-$430.51M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.